01.09.2015 - Google intensifies the work related to the treatment of diabetes

Google announced the beginning of cooperation in the research of department of the health sector with the European pharmaceutical company Sanofi SA in the study and treatment of diabetes. It should be noted that Sanofi SA is the largest producer of drugs against diabetes and other diseases, and Google is working on devices to collect information about patients and their treatment. It is worth noting that Google produces an active investment activities, including in the health sector, which gives reason to expect revenue growth in the long term. We recommend buying shares of companies with growth potential by 35-40% per annum until the end of the year.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.